NCT01393223View on ClinicalTrials.gov

Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

June 14, 2018

Study Completion Date

June 14, 2018

Conditions
Interstitial Cystitis
Interventions
DRUG

LP-08 80mg

Intravesical instillation of 80mg LP08

DRUG

Normal saline

Intravesical instillation of normal saline

DRUG

LP-08 20mg

Intravesical instillation of 20mg LP08

Trial Locations (1)

Unknown

William Beaumont Hospitals, Royal Oak

Sponsors
All Listed Sponsors
collaborator

William Beaumont Hospitals

OTHER

lead

Lipella Pharmaceuticals, Inc.

INDUSTRY

NCT01393223 - Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome | Biotech Hunter | Biotech Hunter